Literature DB >> 18216567

Histopathology of Salzmann nodular corneal degeneration.

Donald U Stone1, Roger A Astley, Robert P Shaver, James Chodosh.   

Abstract

PURPOSE: To define the histopathology of Salzmann nodular degeneration and suggest potential mechanisms involved in its pathogenesis.
METHODS: Archived corneal biopsy specimens from 5 patients with Salzmann nodular degeneration were evaluated by chemical and immunohistochemical staining to describe the structure of the Salzmann nodules and phenotypes of nodule epithelium and stromal cells.
RESULTS: Each Salzmann nodule appeared as a hypercellular mound of extracellular matrix located between a thinned corneal epithelium and a fragmented Bowman layer. Stromal cells within each nodule stained positively for vimentin, consistent with a fibroblast phenotype, whereas the epithelial cells overlying each nodule were positive for matrix metalloproteinase-2 and negative for matrix metalloproteinase-9.
CONCLUSIONS: The observed epithelial expression of matrix metalloproteinase-2 overlying Salzmann nodules is consistent with chronic epithelial wounding in the disorder but does not identify a cause-effect relationship. Salzmann nodules might develop because of enzymatic disruption of the Bowman layer, anterior migration and proliferation of keratocytes, and secondary deposition of extracellular matrix. Alternatively, desiccation secondary to the elevation of the nodule might induce increased epithelial metalloproteinase expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216567     DOI: 10.1097/ICO.0b013e31815a50fb

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  10 in total

1.  [Salzmann's nodular degeneration on a corneal graft 20 years after penetrating keratoplasty for keratoconus].

Authors:  Z Gatzioufas; T Hager; M El-Husseiny; N Kozeis; B Seitz
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

2.  Salzmann nodular degeneration associated with epithelial ingrowth after LASIK treated with superficial keratectomy.

Authors:  Maxwell S Stem; Christopher Thomas Hood
Journal:  BMJ Case Rep       Date:  2015-01-06

3.  Salzmann nodular degeneration features in a case of Kabuki make-up syndrome.

Authors:  Amélia Martins; Mariana Almeida Oliveira; Andreia Rosa; Joaquim Murta
Journal:  BMJ Case Rep       Date:  2019-05-30

4.  Peripheral hypertrophic subepithelial corneal degeneration presenting with bilateral nasal and temporal corneal changes.

Authors:  M Schargus; C Kusserow; U Schlötzer-Schrehardt; C Hofmann-Rummelt; G Schlunck; G Geerling
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

5.  [Salzmann's nodular degeneration. Mostly an epithelial corneal dystrophy].

Authors:  R Sundmacher
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

6.  Salzmann nodular degeneration: prevalence, impact, and management strategies.

Authors:  Vikram Paranjpe; Anat Galor; Pedro Monsalve; Sander R Dubovy; Carol L Karp
Journal:  Clin Ophthalmol       Date:  2019-07-25

7.  Myopic regression and recurrent Salzmann nodule degeneration after laser in situ keratomileusis in Ehlers Danlos Syndrome.

Authors:  Grant C Hopping; Anisha N Somani; Uma Vaidyanathan; Harry Liu; James R Barnes; Yasmyne C Ronquillo; Phillip C Hoopes; Majid Moshirfar
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-04

Review 8.  Optimization of the Ocular Surface Through Treatment of Ocular Surface Disease Before Ophthalmic Surgery: A Narrative Review.

Authors:  Barry Schechter; Francis Mah
Journal:  Ophthalmol Ther       Date:  2022-04-29

9.  Atypical Presentation of Salzmann Nodule: A Case Report and Literature Review.

Authors:  Mohanna Y Aljindan; Malak A Bamashmoos; Reem A AlShamlan; Amal A AlOdaini; Hanoof A Alabdullatif
Journal:  Cureus       Date:  2021-06-02

10.  Salzmann nodular degeneration in posterior keratoconus: a case report.

Authors:  Peng Song; Xiaofei Yu; Chenjiu Pang
Journal:  BMC Ophthalmol       Date:  2022-03-12       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.